Privia Health Group, Inc.
NASDAQ:PRVA
19.07 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Revenue
| 1,657.737 | 1,356.66 | 966.22 | 817.075 | 786.36 | 657.609 |
| Cost of Revenue
| 1,502.769 | 1,221.878 | 902.558 | 734.493 | 717.888 | 601.15 |
| Gross Profit
| 154.968 | 134.782 | 63.662 | 82.582 | 68.472 | 56.459 |
| Gross Profit Ratio
| 0.093 | 0.099 | 0.066 | 0.101 | 0.087 | 0.086 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 109.587 | 129.592 | 255.884 | 44.016 | 41.827 | 41.497 |
| Selling & Marketing Expenses
| 24.732 | 19.741 | 22.75 | 11.343 | 9.156 | 11.737 |
| SG&A
| 134.319 | 149.333 | 278.634 | 55.359 | 50.983 | 53.234 |
| Other Expenses
| 1,502.769 | 4.571 | 2.464 | 1.843 | 1.427 | 1.07 |
| Operating Expenses
| 134.319 | 153.904 | 281.098 | 57.202 | 52.41 | 54.304 |
| Operating Income
| 20.649 | -19.122 | -217.436 | 25.38 | 16.062 | 2.155 |
| Operating Income Ratio
| 0.012 | -0.014 | -0.225 | 0.031 | 0.02 | 0.003 |
| Total Other Income Expenses Net
| 8.372 | 0.542 | -1.07 | -1.917 | -6.91 | -6.42 |
| Income Before Tax
| 29.021 | -18.58 | -218.506 | 23.463 | 9.152 | -4.265 |
| Income Before Tax Ratio
| 0.018 | -0.014 | -0.226 | 0.029 | 0.012 | -0.006 |
| Income Tax Expense
| 7.993 | -6.516 | -27.857 | -7.441 | 1.207 | -0.076 |
| Net Income
| 23.079 | -12.064 | -190.649 | 31.244 | 8.244 | -3.044 |
| Net Income Ratio
| 0.014 | -0.009 | -0.197 | 0.038 | 0.01 | -0.005 |
| EPS
| 0.2 | -0.11 | -1.77 | 0.3 | 0.078 | -0.03 |
| EPS Diluted
| 0.19 | -0.11 | -1.77 | 0.3 | 0.078 | -0.03 |
| EBITDA
| 27.182 | -14.551 | -214.972 | 27.223 | 17.489 | 3.227 |
| EBITDA Ratio
| 0.016 | -0.011 | -0.222 | 0.033 | 0.022 | 0.005 |